A new trading day began on Friday, with PDS Biotechnology Corporation (NASDAQ: PDSB) stock price up 5.19% from the previous day of trading, before settling in for the closing price of $1.35. PDSB’s price has ranged from $0.85 to $4.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 11.00%. With a float of $43.98 million, this company’s outstanding shares have now reached $45.45 million.
The extent of productivity of a business whose workforce counts for 24 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
PDS Biotechnology Corporation (PDSB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of PDS Biotechnology Corporation is 3.78%, while institutional ownership is 17.85%. The most recent insider transaction that took place on Feb 28 ’25, was worth 25,000. In this transaction Director of this company bought 15,060 shares at a rate of $1.66, taking the stock ownership to the 61,213 shares. Before that another transaction happened on Feb 28 ’25, when Company’s Director bought 15,061 for $1.66, making the entire transaction worth $25,001. This insider now owns 78,851 shares in total.
PDS Biotechnology Corporation (PDSB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.75% during the next five years compared to 6.42% growth over the previous five years of trading.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
Here are PDS Biotechnology Corporation’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
The latest stats from [PDS Biotechnology Corporation, PDSB] show that its last 5-days average volume of 0.35 million was inferior to 0.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 78.17%. Additionally, its Average True Range was 0.11.
During the past 100 days, PDS Biotechnology Corporation’s (PDSB) raw stochastic average was set at 42.22%, which indicates a significant decrease from 89.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.93% in the past 14 days, which was lower than the 93.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2110, while its 200-day Moving Average is $2.1483. Now, the first resistance to watch is $1.4600. This is followed by the second major resistance level at $1.5000. The third major resistance level sits at $1.5500. If the price goes on to break the first support level at $1.3700, it is likely to go to the next support level at $1.3200. The third support level lies at $1.2800 if the price breaches the second support level.
PDS Biotechnology Corporation (NASDAQ: PDSB) Key Stats
With a market capitalization of 64.91 million, the company has a total of 45,710K Shares Outstanding. Currently, annual sales are 0 K while annual income is -37,610 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,950 K.
